202 related articles for article (PubMed ID: 25936561)
1. Therapeutic efficacy of artemisinin-loaded nanoparticles in experimental visceral leishmaniasis.
Want MY; Islamuddin M; Chouhan G; Ozbak HA; Hemeg HA; Dasgupta AK; Chattopadhyay AP; Afrin F
Colloids Surf B Biointerfaces; 2015 Jun; 130():215-21. PubMed ID: 25936561
[TBL] [Abstract][Full Text] [Related]
2. Nanoliposomal artemisinin for the treatment of murine visceral leishmaniasis.
Want MY; Islammudin M; Chouhan G; Ozbak HA; Hemeg HA; Chattopadhyay AP; Afrin F
Int J Nanomedicine; 2017; 12():2189-2204. PubMed ID: 28356736
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapeutic Potential of Eugenol Emulsion in Experimental Visceral Leishmaniasis.
Islamuddin M; Chouhan G; Want MY; Ozbak HA; Hemeg HA; Afrin F
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005011. PubMed ID: 27776125
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of artemisinin in experimental visceral leishmaniasis.
Sen R; Ganguly S; Saha P; Chatterjee M
Int J Antimicrob Agents; 2010 Jul; 36(1):43-9. PubMed ID: 20403680
[TBL] [Abstract][Full Text] [Related]
5. A new approach for the delivery of artemisinin: formulation, characterization, and ex-vivo antileishmanial studies.
Want MY; Islamuddin M; Chouhan G; Dasgupta AK; Chattopadhyay AP; Afrin F
J Colloid Interface Sci; 2014 Oct; 432():258-69. PubMed ID: 25086720
[TBL] [Abstract][Full Text] [Related]
6. A novel outlook in the delivery of artemisinin: production and efficacy in experimental visceral leishmaniasis.
Akbari M; Heli H; Oryan A; Hatam G
Pathog Glob Health; 2024 Feb; 118(1):40-46. PubMed ID: 37183476
[TBL] [Abstract][Full Text] [Related]
7. Synergic effect of eugenol oleate with amphotericin B augments anti-leishmanial immune response in experimental visceral leishmaniasis in vitro and in vivo.
Kar A; Jayaraman A; Charan Raja MR; Srinivasan S; Debnath J; Mahapatra SK
Int Immunopharmacol; 2021 Feb; 91():107291. PubMed ID: 33360084
[TBL] [Abstract][Full Text] [Related]
8. Cinnamomum cassia exhibits antileishmanial activity against Leishmania donovani infection in vitro and in vivo.
Afrin F; Chouhan G; Islamuddin M; Want MY; Ozbak HA; Hemeg HA
PLoS Negl Trop Dis; 2019 May; 13(5):e0007227. PubMed ID: 31071090
[TBL] [Abstract][Full Text] [Related]
9. Th1-biased immunomodulation and therapeutic potential of Artemisia annua in murine visceral leishmaniasis.
Islamuddin M; Chouhan G; Farooque A; Dwarakanath BS; Sahal D; Afrin F
PLoS Negl Trop Dis; 2015 Jan; 9(1):e3321. PubMed ID: 25568967
[TBL] [Abstract][Full Text] [Related]
10. Oleanolic acid loaded poly lactic co- glycolic acid- vitamin E TPGS nanoparticles for the treatment of Leishmania donovani infected visceral leishmaniasis.
Ghosh S; Kar N; Bera T
Int J Biol Macromol; 2016 Dec; 93(Pt A):961-970. PubMed ID: 27645930
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome Analysis Identifies Immune Markers Related to Visceral Leishmaniasis Establishment in the Experimental Model of BALB/c Mice.
Agallou M; Athanasiou E; Kammona O; Tastsoglou S; Hatzigeorgiou AG; Kiparissides C; Karagouni E
Front Immunol; 2019; 10():2749. PubMed ID: 31849951
[TBL] [Abstract][Full Text] [Related]
12. Studies on the protective and immunomodulatory efficacy of Withania somnifera along with cisplatin against experimental visceral leishmaniasis.
Sachdeva H; Sehgal R; Kaur S
Parasitol Res; 2013 Jun; 112(6):2269-80. PubMed ID: 23519426
[TBL] [Abstract][Full Text] [Related]
13. Antineoplastic drug, carboplatin, protects mice against visceral leishmaniasis.
Kaur T; Makkar P; Randhawa K; Kaur S
Parasitol Res; 2013 Jan; 112(1):91-100. PubMed ID: 22961311
[TBL] [Abstract][Full Text] [Related]
14. A comparative evaluation of efficacy of chemotherapy, immunotherapy and immunochemotherapy in visceral leishmaniasis-an experimental study.
Joshi J; Malla N; Kaur S
Parasitol Int; 2014 Aug; 63(4):612-20. PubMed ID: 24747611
[TBL] [Abstract][Full Text] [Related]
15. A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice.
Mazumdar T; Anam K; Ali N
Vaccine; 2004 Mar; 22(9-10):1162-71. PubMed ID: 15003644
[TBL] [Abstract][Full Text] [Related]
16. Tinospora cordifolia as a protective and immunomodulatory agent in combination with cisplatin against murine visceral leishmaniasis.
Sachdeva H; Sehgal R; Kaur S
Exp Parasitol; 2014 Feb; 137():53-65. PubMed ID: 24370645
[TBL] [Abstract][Full Text] [Related]
17. Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis.
Bhattacharya P; Dey R; Dagur PK; Joshi AB; Ismail N; Gannavaram S; Debrabant A; Akue AD; KuKuruga MA; Selvapandiyan A; McCoy JP; Nakhasi HL
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004963. PubMed ID: 27580076
[TBL] [Abstract][Full Text] [Related]
18. Studies on the protective efficacy of second-generation vaccine along with standard antileishmanial drug in Leishmania donovani infected BALB/c mice.
Joshi J; Kaur S
Parasitology; 2014 Apr; 141(4):554-62. PubMed ID: 24618257
[TBL] [Abstract][Full Text] [Related]
19. 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
Choudhury R; Das P; De T; Chakraborti T
Immunobiology; 2013 Jan; 218(1):114-26. PubMed ID: 22440312
[TBL] [Abstract][Full Text] [Related]
20. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
Bhattacharya S; Ghosh P; De T; Gomes A; Gomes A; Dungdung SR
Exp Parasitol; 2013 Sep; 135(1):126-33. PubMed ID: 23830987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
